Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;15(5):1138-1146.
doi: 10.5114/aoms.2018.79682. Epub 2018 Nov 23.

Genes and metabolic pathway of sarcoidosis: identification of key players and risk modifiers

Affiliations

Genes and metabolic pathway of sarcoidosis: identification of key players and risk modifiers

Mihailo I Stjepanovic et al. Arch Med Sci. 2019 Sep.

Abstract

Introduction: Sarcoidosis is a rare multisystem granulomatous disease with unknown etiology. The interplay of vitamin D deficiency and genetic polymorphisms in genes coding for the proteins relevant for metabolism of vitamin D is an important, but unexplored area. The aim of this study was to investigate the association between single nucleotide polymorphisms (SNPs) in CYP2R1 (rs10741657), CYP27B1 (rs10877012), DBP (rs7041; rs4588), and VDR (rs2228570) genes and sarcoidosis, as well as the association between these SNPs and 25(OH)D levels in sarcoidosis patients.

Material and methods: For that purpose we genotyped 86 sarcoidosis patients and 50 healthy controls using the PCR-RFLP method.

Results: Subjects carrying the CC genotype of CYP27B1 rs10877012 have 10 times lower odds of suffering from sarcoidosis. Moreover, DBP rs4588 AA genotype was shown to be a susceptibility factor, where carriers of this genotype had eight times higher odds for developing sarcoidosis. In addition, the A allele of the DBP gene (rs4588) was associated with lower levels of 25(OH)D in sarcoidosis patients.

Conclusions: These results suggest that patients with vitamin D deficiency should be regularly tested for genetic modifiers that are related to sarcoidosis in order to prevent development of serious forms of sarcoidosis.

Keywords: 25(OH)D; CYP27B1; CYP2R1; DBP; VDR; single nucleotide polymorphisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of CC vs. CA + AA genotypes of CYP27B1 rs10877012 among sarcoidosis patients and controls
Figure 2
Figure 2
Distribution of AA vs. CA + CC genotypes of DBP rs4588 among sarcoidosis patients and controls
Figure 3
Figure 3
Comparison of 25(OH)D levels between carriers of CC vs. CA + AA genotypes of DBP rs4588. The line inside the box represents the median value, and the box represents the first and third quartile of data

Similar articles

Cited by

References

    1. Culver DA. Sarcoidosis. Immunol Allergy Clin North Am. 2012;32:487–511. - PubMed
    1. Carmona EM, Kalra S, Ryu JH. Pulmonary sarcoidosis: diagnosis and treatment. Mayo Clin Proc. 2016;91:946–54. - PubMed
    1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–65. - PubMed
    1. Gerke AK. Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med. 2014;20:472–8. - PMC - PubMed
    1. Benatar SR. Sarcoidosis in South Africa. A comparative study in Whites, Blacks and Coloureds. South African Med J. 1977;52:602–6. - PubMed